ICER, ISPOR AND QALYs: A Tale of Imaginary Worlds
Previous commentaries in the Formulary Evaluation section of INNOVATIONS in Pharmacy have pointed to the lack of credibility in modeled claims for cost-effectiveness and associated recommendations for pricing by the Institute for Clinical and Economic Review (ICER). The principal objection to ICER r...
Saved in:
| Main Author: | |
|---|---|
| Format: | Book |
| Published: |
University of Minnesota Libraries Publishing,
2019-11-01T00:00:00Z.
|
| Subjects: | |
| Online Access: | Connect to this object online. |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|